Executive Vice President & Chief Operating Officer, CBT Pharmaceuticals
Proventa International will be gathering over 100 C-Level Directors from a mix of emerging to large Pharmaceutical, Biotechnology & Academic/Research Institutions to help solve their key strategic challenges in the area of Oncology.Register Now
The Oncology Roundtable Discussions Strategy Meeting are for qualified end-users. These include Senior Executives of Oncology/Immuno-Oncology (from medium to large Pharma, Biopharma and Biotech players) in global development positions spanning early development to phase IV, as well as thought leaders from Academia and regulatory authorities.
Thought leaders who will benefit from attending include CXOs, EVPs, SVPs, VPs, Executive Directors, Directors and Global Heads responsible for:
– Oncology R&D,Translational Research/Development/Medicine, Clinical Research/Development, Immuno-Oncology, Medical Affairs Oncology,Clinical Pharmacology,Oncology Clinical Biostatistics and Programming, Oncology Clinical Genomics and Computational Biology, Oncology R&D Innovation, Oncology R&D Strategy, Oncology Portfolio/Project Management.
Those who do not qualify for VIP passes, including vendors, exchanges, consultancies and other service providers, can apply here.
Vice President, Therapeutic Area Head, Hematology/Oncology, Jazz Pharmaceuticals
SponsorsSEE OUR SPONSORS
Hyatt Regency San Francisco Airport
1333 Bayshore Highway, Burlingame, California, USA, 94010